Literature DB >> 8489235

The carnitine acyltransferases and their role in modulating acyl-CoA pools.

R R Ramsay1, A Arduini.   

Abstract

The role of carnitine via the action of carnitine acyltransferase in buffering CoA availability in the mitochondrial matrix is well known. There is now sufficient evidence to extend this to a general role. Carnitine can buffer the acylation state of the CoA pool for any type of acyl group that is a substrate for the carnitine acyltransferase family of enzymes. Specific carnitine acyltransferases in each organelle or membrane can modulate the reserves of free CoA and acyl-CoA in ways specific to the local metabolic demands. The use of inhibitors of carnitine acyltransferases in complex systems and in vivo now permits exploration of the consequences of this role.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8489235     DOI: 10.1006/abbi.1993.1216

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  27 in total

Review 1.  The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function.

Authors:  V A Zammit
Journal:  Biochem J       Date:  1999-11-01       Impact factor: 3.857

2.  Pea chloroplast carnitine acetyltransferase.

Authors:  C Masterson; C Wood
Journal:  Proc Biol Sci       Date:  2000-01-07       Impact factor: 5.349

Review 3.  Mitochondria and cardioprotection.

Authors:  Fabio Di Lisa; Marcella Canton; Roberta Menabò; Nina Kaludercic; Paolo Bernardi
Journal:  Heart Fail Rev       Date:  2007-12       Impact factor: 4.214

4.  Mitochondrial oxidative stress-induced transcript variants of ATF3 mediate lipotoxic brain microvascular injury.

Authors:  Tun Nyunt; Monica Britton; Kwanjeera Wanichthanarak; Madhu Budamagunta; John C Voss; Dennis W Wilson; John C Rutledge; Hnin H Aung
Journal:  Free Radic Biol Med       Date:  2019-07-26       Impact factor: 7.376

Review 5.  Carnitine and acylcarnitines: pharmacokinetic, pharmacological and clinical aspects.

Authors:  Stephanie E Reuter; Allan M Evans
Journal:  Clin Pharmacokinet       Date:  2012-09-01       Impact factor: 6.447

6.  Active sites residues of beef liver carnitine octanoyltransferase (COT) and carnitine palmitoyltransferase (CPT-II).

Authors:  N Nic a'Bháird; V Yankovskaya; R R Ramsay
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

7.  Acute exposure to low glucose rapidly induces endothelial dysfunction and mitochondrial oxidative stress: role for AMP kinase.

Authors:  Jingli Wang; Anna Alexanian; Rong Ying; Tinoy J Kizhakekuttu; Kodlipet Dharmashankar; Jeanette Vasquez-Vivar; David D Gutterman; Michael E Widlansky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-29       Impact factor: 8.311

8.  Evaluation of brain long-chain acylcarnitines during cerebral ischemia.

Authors:  J Deutsch; B Kalderon; A D Purdon; S I Rapoport
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

9.  Gene cloning and biochemical characterization of 4-N-trimethylaminobutyraldehyde dehydrogenase II from Pseudomonas sp. 13CM.

Authors:  Md Rezaul Bari; Maizom Hassan; Naoki Akai; Jiro Arima; Nobuhiro Mori
Journal:  World J Microbiol Biotechnol       Date:  2012-12-06       Impact factor: 3.312

10.  Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice.

Authors:  Frank ter Veld; Sonja Primassin; Lars Hoffmann; Ertan Mayatepek; Ute Spiekerkoetter
Journal:  J Lipid Res       Date:  2008-10-31       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.